$1.99
0.052.58%
At close: -
$2.00
0.008800.44%
After Hours: Jun 6, 6:32 PM EDT
Comments
Loading...
Fractyl Health Analyst Ratings and Price Targets | NASDAQ:GUTS | Benzinga
Fractyl Health Inc has a consensus price target of $11 based on the ratings of 3 analysts. The high is $12 issued by Canaccord Genuity on April 15, 2025. The low is $10 issued by Morgan Stanley on February 3, 2025. The 3 most-recent analyst ratings were released by Canaccord Genuity, Morgan Stanley, and Morgan Stanley on April 15, 2025, February 3, 2025, and February 27, 2024, respectively. With an average price target of $13.33 between Canaccord Genuity, Morgan Stanley, and Morgan Stanley, there's an implied 567.07% upside for Fractyl Health Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Canaccord Genuity
Morgan Stanley
1calculated from analyst ratings
Analyst Ratings for Fractyl Health
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 04/15/2025 | Buy Now | 500.36% | Canaccord Genuity | — | → $12 | Initiates | → Buy | Get Alert |
| 02/03/2025 | Buy Now | 400.3% | Morgan Stanley | Michael Ulz64% | $18 → $10 | Maintains | Overweight | Get Alert |
| 02/28/2024 | Buy Now | — | Evercore ISI Group | Umer Raffat43% | — | Initiates | → Outperform | Get Alert |
| 02/27/2024 | Buy Now | 800.54% | Morgan Stanley | Michael Ulz64% | → $18 | Initiates | → Overweight | Get Alert |
FAQ
What is the target price for Fractyl Health (GUTS) stock?
The latest price target for Fractyl Health (NASDAQ:GUTS) was reported by Canaccord Genuity on April 15, 2025. The analyst firm set a price target for $12.00 expecting GUTS to rise to within 12 months (a possible 500.36% upside). 2 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Fractyl Health (GUTS)?
The latest analyst rating for Fractyl Health (NASDAQ:GUTS) was provided by Canaccord Genuity, and Fractyl Health initiated their buy rating.
When was the last upgrade for Fractyl Health (GUTS)?
There is no last upgrade for Fractyl Health
When was the last downgrade for Fractyl Health (GUTS)?
There is no last downgrade for Fractyl Health.
When is the next analyst rating going to be posted or updated for Fractyl Health (GUTS)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Fractyl Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Fractyl Health was filed on April 15, 2025 so you should expect the next rating to be made available sometime around April 15, 2026.
Is the Analyst Rating Fractyl Health (GUTS) correct?
While ratings are subjective and will change, the latest Fractyl Health (GUTS) rating was a initiated with a price target of $0.00 to $12.00. The current price Fractyl Health (GUTS) is trading at is $2.00, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
